Vasculitis & polymyalgia rheumatica
Real-world outcomes of a dedicated fast-track polymyalgia rheumatica clinic
Study context
- Population
- Patients over 50 years referred from primary care with suspected new PMR (new onset shoulder or pelvic girdle pain and/or stiffness with elevated inflammatory markers) to a fast-track PMR clinicreferred over 12 months
- Participants
- 172 participants
- Outcome
- Clinical impact of fast-track PMR clinic and characteristics of new PMR
Methodological detailsreal-world, fast-track clinic, patients seen within 72 h of referral
- Real-world
- Fast-track clinic, patients seen within 72 h of referral
Main finding
As reported in the abstract
- Referred with suspected PMR but alternative diagnosis for which PMR regimen GC was inappropriate
- 39%
- Non-PMR diagnoses that were other inflammatory rheumatological conditions requiring follow-up
- 55%
- Patients referred already on GC who were commenced on bone protection
- 20%
- Other comorbid conditions in PMR patients, mean
- 2.5
- New PMR with US features of subclinical GCA
- 17%
Observational data: associations, not effects.
Safety
GC-related adverse event in PMR patients · first 12 months of treatment
- PMR patients with a GC-related adverse event
- 75%
Original publication
Real-world outcomes of a dedicated fast-track polymyalgia rheumatica clinic. Rheumatology (Oxford). Published 30 September 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →